CG Oncology Inc. Common s...
(CGON) ✕
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
undefined
undefined%
At close: undefined
30.52
0.07%
After-hours Jan 03, 2025, 04:00 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year | FY23 | FY22 | FY21 |
Revenue | 204.00K | 191.00K | 10.36M |
Cost of Revenue | n/a | 15.00K | 10.00K |
Gross Profit | 204.00K | 176.00K | 10.35M |
Operating Income | -55.45M | -35.25M | -12.61M |
Interest Income | n/a | n/a | n/a |
Pretax Income | -48.61M | -35.44M | -12.84M |
Net Income | -48.61M | -35.44M | -12.84M |
Selling & General & Admin | 9.90M | 6.39M | 4.63M |
Research & Development | 45.75M | 29.03M | 18.32M |
Other Expenses | n/a | -196.00K | 218.00K |
Operating Expenses | 55.65M | 35.42M | 22.95M |
Interest Expense | n/a | 1K | 451.00K |
Selling & Marketing Expenses | n/a | -15.00K | -10.00K |
Cost & Expenses | 55.65M | 35.44M | 22.96M |
Income Tax | n/a | n/a | n/a |
Shares Outstanding (Basic) | 4.33M | 66.64M | 66.64M |
Shares Outstanding (Diluted) | 4.33M | 66.64M | 66.64M |
EPS (Basic) | -15.65 | -0.53 | -0.19 |
EPS (Diluted) | -15.65 | -0.53 | -0.19 |
EBITDA | -55.43M | -35.23M | -12.38M |
Depreciation & Amortization | 17.00K | 15.00K | 10.00K |